Sindhudurg, Maharashtra – 416520
+91 8080485895
+91 7588783924
Parotid Cancer refers to malignancies that develop in the parotid glands, the largest of the salivary glands, located on both sides of the face just in front of the ears. These glands are responsible for producing saliva, which helps with digestion, oral hygiene, and keeping the mouth moist.
At Konkan Cancer Hospital (KCH), we specialize in the comprehensive evaluation, accurate diagnosis, and advanced treatment of parotid tumors — both benign and malignant. Our head and neck oncology team brings cutting-edge expertise and compassionate care to patients across Sindhudurg, Kolhapur, Ratnagiri, Goa, and nearby regions.
Parotid gland cancer typically arises due to mutations in the salivary gland cells, which cause uncontrolled cell growth and the formation of tumors. While the exact cause isn’t always clear, several risk factors have been associated with this condition:
Several histological types of tumors can arise in the parotid glands. The most commonly diagnosed include:
Mucoepidermoid Carcinoma: The most frequent type, varying from low to high grade.
Adenoid Cystic Carcinoma (ACC): Slow-growing but can spread along nerves.
Acinic Cell Carcinoma: Often low grade and less aggressive.
Adenocarcinoma: Arises from glandular tissue; can be more invasive.
Carcinoma ex Pleomorphic Adenoma: A malignant transformation of a benign tumor.
Early detection is crucial. Be alert for:
A painless lump or swelling near the ear or jawline
Facial weakness or numbness, especially on one side
Difficulty swallowing or speaking
Persistent pain in the jaw, neck, or ear
A visible or palpable mass in front of or below the ear
Asymmetry of the face
Persistent ulcers or mouth lesions
If you notice any of these signs, contact Konkan Cancer Hospital (KCH) for a timely and expert evaluation.
Understanding the cancer’s extent helps determine the treatment approach:
Stage I: Tumor ≤2 cm, no spread
Stage II: Tumor 2–4 cm, no lymph node involvement
Stage III: Tumor >4 cm or spread to one nearby lymph node
Stage IV: Tumor spread to multiple lymph nodes or distant organs
Low Grade (Well Differentiated): Slow-growing, less aggressive
High Grade (Poorly Differentiated): Fast-growing, higher risk of spread
We follow an evidence-based diagnostic pathway for accurate assessment:
Physical Examination: Check for visible or palpable masses
Ultrasound & Doppler: First-line imaging for parotid gland evaluation
Fine Needle Aspiration (FNA) Biopsy: Gold standard for cytology
MRI / CT Scans: Assess tumor size, invasion, and lymph node involvement
PET-CT: For staging and detecting metastasis
Histopathological Study: Confirms the type and grade of cancer
Our multidisciplinary tumor board designs a personalized treatment plan using:
Superficial or total parotidectomy based on the tumor location
Facial nerve preservation or reconstruction if involved
Neck dissection in case of lymph node spread
Intensity-Modulated Radiation Therapy (IMRT) for precise targeting
Often used post-surgery to minimize recurrence
Used in advanced or recurrent cases
Can be combined with radiation (chemoradiation)
For selected high-grade or metastatic cases
Under clinical trial or precision oncology protocol
The gold standard for most parotid gland cancers is surgical resection followed by radiation therapy, especially for high-grade or advanced-stage tumors. This combination provides the best chance of local control and long-term survival.
Early-stage (I & II): 5-year survival rates range from 80–95%
Intermediate-stage (III): Moderate prognosis with combined treatment
Advanced-stage (IV): Challenging but manageable with multimodal therapy
Tumor grade and facial nerve involvement are key prognostic factors
We offer structured follow-up including:
Regular clinical exams and imaging every 3–6 months for the first 2 years
Long-term surveillance for late recurrence
Speech therapy and facial rehabilitation if required
Nutritional support and psychological counseling
Not always. Many salivary gland lumps are benign, but evaluation is essential.
Konkan Cancer Center surgeons use nerve-monitoring to minimize nerve damage. In some cases, partial weakness may occur and often improves over time.
Yes, especially in high-grade tumors. Hence, long-term follow-up is necessary.
Yes, selected cases may benefit from endoscopic or nerve-sparing techniques.
Konkan Cancer Hospital (KCH), Kudal offers expert diagnosis, advanced treatment, and dedicated care for salivary gland cancers.
Don’t ignore the warning signs. If you have a lump near your jaw, facial weakness, or unexplained swelling, consult our expert head and neck cancer team today.